Discussion on the Treatment Mechanism of Adverse Events Following Immunization in China

doi:10.19803/j.1672-8629.2021.04.07

Abstract

Abstract: Objective Comparing the vaccine injury relief system established by the damage caused by vaccination in 25 typical countries of the World Health Organization, Studying the relevant provisions in the "Vaccine Administration Law", provides ideas for the AEFI compensation system. Methods Using intelligence research and literature qualitative analysis methods to compare and analyze the characteristics of vaccine injury rescue mechanisms in the United States, New Zealand, Europe, and Japan. Studying and analyzing the corresponding provisions of the 2019 Vaccine Law. Results Each country’s vaccine injury treatment mechanism has its own advantages and disadvantages. China 2019 Vaccine Law provides guiding opinions on AEFI compensation, but there is still a lack of corresponding rescue regulations and rules. Conclusion In accordance with the relevant provisions of the 2019 Vaccine Law, China should introduce a unified national rescue system and detailed rules as soon as possible, consider raising subsidy funds from multiple sources, protect the interests of all parties, and maintain a harmonious vaccine use environment.

Key words: vaccines, AEFI, vaccine law, compensation system

CLC Number:

R994.11

ZHONG Zhilei, YIN Xingxiao, LIANG Yan, SHI Haoyu, FU Jie, YANG Jingsi. Discussion on the Treatment Mechanism of Adverse Events Following Immunization in China[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 328-333.

References

[1] Looker C, Kelly H.No-fault compensation following adverse events attributed to vaccination: a reviewof international programmes[J]. Bull World Health Organ, 2011, 89: 371-378.
[2] Cook KM, Evans G.The national vaccine injury compensation program[J]. Pediatrics, 2011, 127(Suppl1) S74-S77.
[3] Mungwira RG, Guillard C, Saldaa A, et al.Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries[J]. PLoS One, 2020, 15(5): e0233334.
[4] Fei L, Peng Z.No-fault compensation for adverse events following immunization: A review of chinese law and practice[J]. Medical Lawreview, 2017, 25(1): 99-114.
[5] Ihara T.The national vaccine injury compensation program in Japan[J]. Nihon Rinsho Japanese Journal of Clinical Medicine, 2011, 69(9): 1645-1650.
[6] Kim MK, Lee YK, Kim TE, et al.Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea[J]. Clinical and Experimental Vaccine Research 2017, 6(2): 146-155.
[7] Thompson KM, Orenstein WA, Hinman AR.Performance of the united states vaccine injury compensation program (VICP): 1988-2019[J]. Vaccine, 2020, 38( 9): 2136-2143.
[8] Anne-Maree F, Sarah D, Amber D, No-fault compensation schemes for medical injury: A Review[J]. SSRN Electronic Journal, 2010. DOI: 10. 2139/ssrn. 2221836
[9] Mungwira RG. Maure CG, Zuber PLF.Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries[J]. Vaccine, 2019, 37(31): 4370-4375.
[10] Nelson MR.A no-fault compensation scheme for serious adverse events attributed to vaccination[J]. The Medical Journal of Australia, 2011, 195(5): 263.
[11] Hrsa RSA.National Vaccine Injury Compensation Program: revisions to the vaccine injury table. Final rule.[J]. Federal Register, 2011, 82(120): 6294-6305.
[12] Zhang Z. Vaccine Litigation:reality and fiction in American courts [N/OL]. Sciencene(科学网),[2017-05-07]. http://news.sciencenet.cn/htmlnews/2017/5/375414.shtm.
[13] Yang Y.Speed up the formulation of "Vaccine administration law of the people's Republic of China " and improve the compensation mechanism of vaccine abnormal reaction[J]. China Food & Drug Administration Magazine(中国食品药品监管), 2019(3): 4-9.
[14] Vaccine administration law of the people's Republic of China [N]. The People's Daily(人民日报), 2019-08-14(14).
[15] Ministry of health of China. National surveillance program for suspected adverse reactions to vaccination[J]. Chinese Journal of Vaccines and Immunization(中国疫苗和免疫), 2011, 17(1):72-81.
[16] Wang YF,Yang LN,Yang Y.Study on vaccine injury compensation trust fund in the United States and its enlightenment to China[J]. China Pharmacy(中国药房),2020, 31(12): 1419-1424.
[17] Ding CY.The establishment of national compensation system of adverse event following immunization: Comparative analysis based on different local compensation standards[J]. Chinese Health Economics(中国卫生经济), 2018, 37(11): 5-8.